Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
Clinical trial NCT01067443 · COMPLETED
Trial details
- NCT number
- NCT01067443
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-06-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.